Epithelial and Mesenchymal Features of Pancreatic Ductal Adenocarcinoma Cell Lines in Two- and Three-Dimensional Cultures
Open Access
- 4 May 2022
- journal article
- review article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (5) , 746
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an intractable cancer that is difficult to diagnose early, and there is no cure other than surgery. PDAC is classified as an adenocarcinoma that has limited effective anticancer drug and molecular-targeted therapies compared to adenocarcinoma found in other organs. A large number of cancer cell lines have been established from patients with PDAC that have different genetic abnormalities, including four driver genes; however, little is known about the differences in biological behaviors among these cell lines. Recent studies have shown that PDAC cell lines can be divided into epithelial and mesenchymal cell lines. In 3D cultures, morphological and functional differences between epithelial and mesenchymal PDAC cell lines were observed as well as the drug effects of different anticancer drugs. These effects included gemcitabine causing an increased growth inhibition of epithelial PDAC cells, while nab-paclitaxel caused greater mesenchymal PDAC cell inhibition. Thus, examining the characteristics of epithelial or mesenchymal PDAC cells with stromal cells using a 3D co-culture may lead to the development of new anticancer drugs.Keywords
Funding Information
- Japan Society for the Promotion of Science (19K11759, 19K09207, 21K08744, 21K08764)
This publication has 63 references indexed in Scilit:
- Nestin and other putative cancer stem cell markers in pancreatic cancerMedical Molecular Morphology, 2012
- Enhanced Expression of Fibroblast Growth Factor Receptor 2 IIIc Promotes Human Pancreatic Cancer Cell ProliferationThe American Journal of Pathology, 2012
- Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomasLaboratory Investigation, 2011
- Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomasBritish Journal of Cancer, 2011
- Cancer Stem-Like Cells Enriched in Panc-1 Spheres Possess Increased Migration Ability and Resistance to GemcitabineInternational Journal of Molecular Sciences, 2011
- Pancreatic cancer spheres are more than just aggregates of stem marker-positive cellsBioscience Reports, 2010
- Mammalian Target of Rapamycin Contributes to the Acquired Apoptotic Resistance of Human Mesothelioma Multicellular SpheroidsJournal of Biological Chemistry, 2008
- Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic CancerCell Stem Cell, 2007
- Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem CellsCancer Research, 2006
- Tenascin C and annexin II expression in the process of pancreatic carcinogenesisThe Journal of Pathology, 2006